Trial Profile
Phase 3 Study to Assess the Efficacy and Safety of Frovatriptan.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 31 Jan 2019
Price :
$35
*
At a glance
- Drugs Frovatriptan (Primary)
- Indications Migraine with aura; Migraine without aura
- Focus Therapeutic Use
- Acronyms FRESH
- Sponsors SK Chemicals
- 19 Jan 2009 New trial record.